Implications for KRAS status and EGFR-targeted therapies in metastatic CRC

Peter McIntyre, Ruth Jepson, Stephen Leeder, Les Irwig, The outcome of childhood Haemophilus influenzae meningitis. A population based study. The Medical Journal of Australia. ,vol. 159, pp. 766- 772 ,(1993) , 10.5694/J.1326-5377.1993.TB141344.X

Werner Scheithauer, Alois Lang, Thomas Winder, K-ras mutations and cetuximab in colorectal cancer. The New England Journal of Medicine. ,vol. 360, pp. 834- 834 ,(2009)

G. I Meling, P Laurent-Puig, B. J Iacopetta, R Glaesener, O. P. F Clausen, F Al-Mulla, W Giaretti, V. J Bubb, A. F. P. M de Goeij, G Gaudernack, T Ohkusa, P Quirke, A Rapallo, N Hawkins, R Rosell, T. O Rognum, S. N Andersen, R Smith, J Costa, R Ward, I Hoffmann, T Fujimori, D Cunningham, D Morton, C. T Croke, J Oates, X. F Sun, S Bell, P. A Clarke, S. T Wang, J Breivik, O Muller, A. R Norman, J. W Arends, M Pauly, D Dillon, H. J. N Andreyev, S. D Finkelstein, A. J Senagore, C. N Hall, K Wilkinson, N Lees, N. R Cruickshank, H. S Goh, D Snary, E Jullian, C Valavanis, L Losi, A Russo, H. M Rabes, J Piris, S Wadler, Y Ono, T Azuma, A Font, C Zietz, M Beranek, J. C Fox, S. A Halter, R Benamouzig, B. R Dix, H Zhang, C Faber, K Omura, V. E Pricolo, C Troungos, K Krtolica, J Benhattar, J. W. C Ho, N. Urosevic, T Lovig, D. P O'Donoghue, J. S Thebo, P De Angelis, J. Q Lee, J Young, Bazan, P Jandik, S Olschwang, S. T Yuen, T Walsh, S Malik, M Tanaka, Kirsten ras mutations in patients with colorectal cancer : the ‘RASCAL II’ study Faculty of Health; Institute of Health and Biomedical Innovation. ,vol. 85, pp. 692- 696 ,(2001)

F. Loupakis, L. Pollina, I. Stasi, G. Masi, N. Funel, M. Scartozzi, I. Petrini, D. Santini, S. Cascinu, A. Falcone, Evaluation of PTEN expression in colorectal cancer (CRC) metastases (mets) and in primary tumors as predictors of activity of cetuximab plus irinotecan treatment Journal of Clinical Oncology. ,vol. 26, pp. 4003- 4003 ,(2008) , 10.1200/JCO.2008.26.15_SUPPL.4003

G. G. Kelley, Phospholipase Cepsilon: a novel Ras effector The EMBO Journal. ,vol. 20, pp. 743- 754 ,(2001) , 10.1093/EMBOJ/20.4.743

Rob MF Wolthuis, Johannes L Bos, Ras caught in another affair: the exchange factors for Ral. Current Opinion in Genetics & Development. ,vol. 9, pp. 112- 117 ,(1999) , 10.1016/S0959-437X(99)80016-1

Theresa P. Pretlow, Thomas G. Pretlow, Mutant KRAS in aberrant crypt foci (ACF): initiation of colorectal cancer? Biochimica et Biophysica Acta. ,vol. 1756, pp. 83- 96 ,(2005) , 10.1016/J.BBCAN.2005.06.002

Nicola Personeni, Steffen Fieuws, Hubert Piessevaux, Gert De Hertogh, Jef De Schutter, Bart Biesmans, Wendy De Roock, An Capoen, Maria Debiec-Rychter, Jean-Luc Van Laethem, Marc Peeters, Yves Humblet, Eric Van Cutsem, Sabine Tejpar, Clinical usefulness of EGFR gene copy number as a predictive marker in colorectal cancer patients treated with cetuximab : A fluorescent in situ hybridization study Clinical Cancer Research. ,vol. 14, pp. 5869- 5876 ,(2008) , 10.1158/1078-0432.CCR-08-0449

Robert T. Belly, Joseph D. Rosenblatt, Michele Steinmann, Jacqueline Toner, Jianbo Sun, Joseph Shehadi, James L. Peacock, Richard F. Raubertas, Niraj Jani, Charlotte K. Ryan, Detection of mutated K12-ras in histologically negative lymph nodes as an indicator of poor prognosis in stage II colorectal cancer. Clinical Colorectal Cancer. ,vol. 1, pp. 110- 116 ,(2001) , 10.3816/CCC.2001.N.011

Shuji Ogino, Takako Kawasaki, Mohan Brahmandam, Liying Yan, Mami Cantor, Chungdak Namgyal, Mari Mino-Kenudson, Gregory Y. Lauwers, Massimo Loda, Charles S. Fuchs, Sensitive Sequencing Method for KRAS Mutation Detection by Pyrosequencing The Journal of Molecular Diagnostics. ,vol. 7, pp. 413- 421 ,(2005) , 10.1016/S1525-1578(10)60571-5